Table 4.

Models Examining the Effect of Baseline Aggression on Each Outcome Variable Across the Post-Acute-Treatment Period Controlling for Baseline Severity

Measure	Estimate	SE	t	df	p
SIGH-A
Intercept	11.52	.40	28.76	253	<.0001
Slope over Time (MA2-MA4)	−.16	.03	−5.93	351	<.0001
SIGH-A (MA1)	.31	.04	7.79	351	<.0001
Aggression (MA1)	1.18	.44	2.67	351	.0079
PDSS
Intercept	6.61	.25	26.14	253	<.0001
Slope over Time (MA2-MA4)	−.13	.02	−8.17	367	<.0001
PDSS (MA1)	.22	.05	3.96	367	<.0001
Aggression (MA1)	.43	.28	1.53	367	.127
SIGH-D
Intercept	7.76	.31	25.02	253	<.0001
Slope over Time (MA2-MA4)	−.10	.02	−4.45	351	<.0001
SIGH-D (MA1)	.30	.04	7.35	351	<.0001
Aggression (MA1)	.66	.33	1.96	351	.051
WSAS
Intercept	5.71	.32	17.94	249	<.0001
Slope over Time (MA2-MA4)	−.09	.02	−3.96	320	<.0001
WSAS (MA1)	.29	.03	8.19	320	<.0001
Aggression (MA1)	.28	.36	0.79	320	.43

Note. MA1 assessment occurred pre-acute treatment. MA2 assessment occurred post-acute treatment. MA2-MA4 is the period following post-acute-treatment. Intercept refers to the score of each measure at MA2, controlling for MA1. A significant intercept value indicates that the score at MA2 significantly differed from zero, controlling for MA1. Slope over Time estimates refer to changes in the score of each measure per month during MA2-MA4, controlling for MA1. Significant Slope over Time estimates indicate that a variable showed significant improvement over MA2-MA4. Each measure at MA1 represents the use of baseline measures to control for initial severity. Significant values for a measure indicates that baseline estimates significantly differed from zero. Aggression (MA1) estimates indicate whether individuals with higher baseline aggression exhibited higher scores on the respective measures during MA2-MA4. Significant p-values for Aggression (MA1) indicate that individuals higher in aggression showed less improvement on the respective measure over MA2-MA4.